Multimodality Imaging in Valvular Structural Interventions-Reference-Cited by-同舟云学术

Multimodality Imaging in Valvular Structural Interventions

Published:2022-11-18 Issue: Volume: Page:
ISSN:2057-7559
Container-title:Cardiac Failure Review
language:en
Short-container-title:Card Fail Rev

Author:

Grigoryan Karine¹,Demetrescu Camelia¹,Kasouridis Ioannis¹,Abiola Olukayode¹,Giorgio Masci Pier²,Oguz Didem³,Benedetti Giulia⁴,SzeMun Mak⁴,Parwani Purvi⁵,Preston Rebecca⁴,Chiribiri Amedeo²,Hancock Jane¹,Patterson Tiffany¹,Redwood Simon¹,Prendergast Bernard¹,Grapsa Julia¹

Affiliation:

1. Department of Cardiology, Guys and St Thomas’ NHS Foundation Trust, London, UK

2. Department of Cardiac Magnetic Resonance, Guys and St Thomas’ NHS Foundation Trust, London, UK

3. Department of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, US

4. Department of Radiology, Guys and St Thomas’ NHS Foundation Trust, London, UK

5. Division of Cardiology, Department of Medicine, Loma Linda University Health, California, US

Abstract

Structural valvular interventions have skyrocketed in the past decade with new devices becoming available and indications for patients who would previously have been deemed inoperable. Furthermore, while echocardiography is the main imaging tool and the first line for patient screening, cardiac magnetic resonance and CT are now essential tools in pre-planning and post-procedural follow-up. This review aims to address imaging modalities and their scope in aortic, mitral and tricuspid structural valvular interventions, including multimodality imaging. Pulmonary valve procedures, which are mostly carried out in patients with congenital problems, are discussed. This article presents a guide on individualised imaging approaches on each of the available interventional procedures.

Publisher

Radcliffe Media Media Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference70 articles.

1. Iung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 2019;140:1156–69. https://doi.org/10.1161/CIRCULATIONAHA.119.041080; PMID: 31510787.

2. Writing Committee Members; Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Thorac Cardiovasc Surg 2021;162:e183–353. https://doi.org/10.1016/j.jtcvs.2021.04.002; PMID: 33972115.

3. Thaden JJ, Nkomo VT, Enriquez-Sarano M. The global burden of aortic stenosis. Prog Cardiovasc Dis 2014;56:565–71. https://doi.org/10.1016/j.pcad.2014.02.006; PMID: 24838132.

4. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561–632. https://doi.org/10.1093/eurheartj/ehab395; PMID: 34453165.

5. Nishimura RA, O’Gara PT, Bavaria JE, et al. 2019 AATS/ACC/ASE/SCAI/STS expert consensus systems of care document: a proposal to optimize care for patients with valvular heart disease: a joint report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. Ann Thorac Surg 2019;107:1884–910. https://doi.org/10.1016/j.athoracsur.2019.03.001; PMID: 31010643.